Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization

Retina

Volumn 31, Issue 5, 2011, Pages 871-879

  Rouvas, Alexander ^a,b   Petrou, Petros ^a   Douvali, Maria ^a   Ntouraki, Amalia ^a   Vergados, Ioannis ^a   Georgalas, Ilias ^a   Markomichelakis, Nikolaos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Gennimatas Hospital ^*  (Greece)

Author keywords

CNV; inflammation; intravitreal injection; ranibizumab

Indexed keywords

ANTIBIOTIC AGENT; INDOCYANINE GREEN; RANIBIZUMAB;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DRUG SCREENING; EARLY INTERVENTION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; REMISSION; RETROSPECTIVE STUDY; SCLERODERMA; SUBRETINAL NEOVASCULARIZATION; THICKNESS; TOXOPLASMOSIS; VISUAL ACUITY;

EID: 79955566732     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182003ca8     Document Type: Article

References (17)

1. Perentes Y, Van Tran T, Sickenberg M, Herbort CP. Subretinal neovascularmembranes complicating uveitis: frequency, treatments, and visual outcome. Ocul Immunol Inflamm 2005;13:219-224. (Pubitemid 41711294)
2. Adán A, Mateo C, Navarro R, Bitrian E, Casaroli-Marano RP. Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina 2007;27:1180-1186. (Pubitemid 350211522)
3. Coco RM, de Souza CF, Sanabria MR. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm 2007;15:27-29. (Pubitemid 46328436)
4. Lim JI, Flaxel CJ, LaBree L. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 2006;35:198-202.
5. Adán A, Mateo C, Wolley-Dod C. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. Am J Ophthalmol 2003;135:386-387.
6. Brown DM, Kaiser PK,Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444. (Pubitemid 44511558)
7. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)
8. Fine HF, Zhitomirsky I, Freund KB, et al. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis. Retina 2009;29:8-12.
9. Doctor PP, Bhat P, Sayed R, Foster CS. Intravitreal bevacizumab for uveitic choroidal neovascularization. Ocul Immunol Inflamm 2009;17:118-126.
10. Mansour AM, Arevalo JF, Ziemssen F, et al. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2009;148: 310.e2-316.e2.
11. Mansour AM, Mackensen F, Arevalo JF, et al. Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2008;146:410-416.
12. Chevalley G, Brazitikos PD, Paccolat F, Pournaras CJ. [Uveitis complicating posterior segment neovascularization. Six cases]. Klin Monbl Augenheilkd 1992;200:382-385.
13. Soubrane G, Coscas G, Binaghi M, Amalric P, Bernard JA. Birdshot retinochoroidopathy and subretinal new vessels. Br J Ophthalmol 1983;67:461-467. (Pubitemid 13066614)
14. Perentes Y, Chan CC, Bovey E, Uffer S, Herbort CP. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease. Klin Monbl Augenheilkd 2002;219:311-314. (Pubitemid 34625244)
15. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99-109. (Pubitemid 27106924)
16. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1891-1898. (Pubitemid 29365148)
17. Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular agerelated macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009;148:43.e1-58.e1.